Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

T-Bird Pharma Inc. V.TPI

Healthcare Biotechnology


TSXV:TPI - Post by User

T-Bird Pharma Inc. > magician
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by CasusFortuituson Jun 25, 2015 3:34am
151 Views
Post# 23866625

RE:magician

RE:magicianLooks like WEX pretty much sold out to CK Life Sciences to satisfy a $15Million convertible debenture in 2009 (with Huang at the helm), then was merged (amalgamated) with Pharmagesic Inc. (a wholly owned subsidiary of CK Life Sciences) in 2011. 

The cautionary tale here seems to be: avoid convertible debentures.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities